SGLT-2 Inhibitors and Peripheral Artery Disease: A Statistical Hoax or Reality?-Reference-Cited by-同舟云学术

SGLT-2 Inhibitors and Peripheral Artery Disease: A Statistical Hoax or Reality?

Published:2019-07 Issue:7 Volume:44 Page:207-222
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Chatterjee Subhankar,Bandyopadhyay Dhrubajyoti,Ghosh Raktim K.,Majumdar Uddalak,Aneja Ashish,Lavie Carl J.,Deedwania Prakash

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference58 articles.

1. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management;Beckman;JAMA,2002

2. Peripheral arterial disease in people with diabetes;Diabetes Care,2003

3. Peripheral arterial disease and risk of cardiac death in type 2 diabetes: The fremantle diabetes study;Norman;Diabetes Care,2006

4. Incidence of diabetic foot ulcer and lower extremity amputation among Medicare beneficiaries, 2006 to 2008: Data Points #2. 2011 Feb 17;Margolis,2011

5. Insulin therapy increases cardiovascular risk in type 2 diabetes;Herman;Prog Cardiovasc Dis,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of SGLT1, SGLT2, and Dual Inhibitor Biological Activity in Treating Type 2 Diabetes Mellitus;Advanced Therapeutics;2023-09-28

2. Peripheral Artery Disease;Medical Clinics of North America;2023-09

3. Comparisons of new-onset peripheral arterial disease in Type 2 diabetes mellitus patients exposed to SGLT2I, DPP4I or GLP1a: a population-based cohort study;2023-08-22

4. Adverse cardiovascular, limb, and renal outcomes in patients with diabetes after peripheral artery disease revascularization treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors;Diabetology & Metabolic Syndrome;2023-01-18

5. Adverse cardiovascular, limb, and renal outcomes in patients with diabetes after peripheral artery disease revascularization treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors Cover title: SGLT2i versus DPP4i in T2D patients after PAD revascularization;2022-10-19